Brief: Allurion Announces Landmark Peer-Reviewed Publication On Consecutive Use Of The Allurion Smart Capsule
07/10/2025 13:44
Oct 7 (Reuters) - Allurion Technologies Inc ALUR.N: ALLURION ANNOUNCES LANDMARK PEER-REVIEWED PUBLICATION ON CONSECUTIVE USE OF THE ALLURION SMART CAPSULE SHOWING MORE THAN 20% WEIGHT LOSS Source text: ID:nBw3fxh9Sa Further company coverage: ALUR.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy